Rosetta Genomics Pays Off Secured Loan and Reclaims Unencumbered Rights to All Assets
PHILADELPHIA and REHOVOT, Israel, June 22, 2012 /PRNewswire/ -- Rosetta Genomics , a leading developer and provider of microRNA-based molecular diagnostic assays, today announced that the Company has entered into an agreement and release with the holders of the $1,750,000 senior secured debenture the Company sold and issued on January 27, 2012.
Join the discussion below, or Read more at Freshnews.
#1 Jun 26, 2012
Is ROSG more than doubling in its value soon?
Check the full article here:
Add your comments below
|Family Gets $4.5 Million In Asbestos Suit (Jun '09)||Sep '16||AshleyStafford||13|
|viagra 'linked to hearing loss' (Mar '16)||Apr '16||Walls||5|
|buy ed meds here and others (Apr '16)||Apr '16||West||1|
|viagra - use and misuse (Mar '16)||Apr '16||Strong||3|
|help guide for asia mesothelioma (May '15)||Feb '16||James Scott||2|
|Study suggests improvements in how mesothelioma... (Feb '16)||Feb '16||James Scott||1|
|Mesothelioma Lawyer Johnson Still Worries About... (Aug '07)||Jan '16||James Scott||8|
Find what you want!
Search Mesothelioma Forum Now
Copyright © 2016 Topix LLC